Stock Analysts’ Updated EPS Estimates for November 14th (ALLO, ANAB, ARHS, BOX, BPMC, CBOE, CRVO, EWCZ, FDMT, FNKO)

Stock Analysts’ updated eps estimates for Thursday, November 14th:

Allogene Therapeutics (NASDAQ:ALLO) had its outperform rating reissued by analysts at William Blair.

AnaptysBio (NASDAQ:ANAB) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $42.00 price target on the stock.

Arhaus (NASDAQ:ARHS) was upgraded by analysts at Telsey Advisory Group from a market perform rating to an outperform rating. They currently have $12.00 target price on the stock, up from their previous target price of $11.00.

BOX (NYSE:BOX) had its outperform rating reissued by analysts at William Blair.

Blueprint Medicines (NASDAQ:BPMC) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $135.00 price target on the stock.

Cboe Global Markets (NASDAQ:CBOE) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

CervoMed (NASDAQ:CRVO) had its buy rating reaffirmed by analysts at Chardan Capital. They currently have a $55.00 target price on the stock.

European Wax Center (NASDAQ:EWCZ) had its outperform rating reissued by analysts at Telsey Advisory Group. They currently have a $8.00 target price on the stock.

4D Molecular Therapeutics (NASDAQ:FDMT) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $39.00 target price on the stock.

Funko (NASDAQ:FNKO) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $16.00 target price on the stock.

Hut 8 (NASDAQ:HUT) had its price target increased by Canaccord Genuity Group Inc. from $22.00 to $32.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.

Janux Therapeutics (NASDAQ:JANX) had its outperform rating reissued by analysts at William Blair.

Lulu’s Fashion Lounge (NASDAQ:LVLU) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $2.00 target price on the stock.

OptimizeRx (NASDAQ:OPRX) had its outperform rating reissued by analysts at William Blair.

Passage Bio (NASDAQ:PASG) had its buy rating reiterated by analysts at Chardan Capital. They currently have a $7.00 price target on the stock.

Pure Storage (NYSE:PSTG) had its outperform rating reaffirmed by analysts at William Blair.

Safe Bulkers (NYSE:SB) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a $6.00 price target on the stock.

Silence Therapeutics (NASDAQ:SLN) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $55.00 target price on the stock.

Taysha Gene Therapies (NASDAQ:TSHA) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $7.00 target price on the stock.